# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
BIO-key Intl (NASDAQ:BKYI) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.15...
BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer identity and access management (IA...